These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8619666)

  • 1. [-Axillary lymph node excision: for what reasons and indications-].
    Schäfer P
    Arch Gynecol Obstet; 1995; 256 Suppl():S81-4. PubMed ID: 8619666
    [No Abstract]   [Full Text] [Related]  

  • 2. [-Breast neoplasms: axillary lymph node excision--at what price-].
    Rageth JC
    Arch Gynecol Obstet; 1995; 256 Suppl():S85-92. PubMed ID: 8619667
    [No Abstract]   [Full Text] [Related]  

  • 3. [Axillary lymph node excision in breast carcinoma].
    Rageth JC; Schreiner WE
    Schweiz Rundsch Med Prax; 1988 Nov; 77(48):1318-21. PubMed ID: 3064243
    [No Abstract]   [Full Text] [Related]  

  • 4. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
    Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
    Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor.
    Fehm T; Maul H; Gebauer S; Scharf A; Baier P; Sohn C; Jäger W; Gebauer G
    Strahlenther Onkol; 2005 Sep; 181(9):580-6. PubMed ID: 16170485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillary staging utilizing selective sentinel lymphadenectomy for patients with invasive breast carcinoma.
    Dale PS; Williams JT
    Am Surg; 1998 Jan; 64(1):28-31; discussion 32. PubMed ID: 9457034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma.
    Kuru B; Bozgul M
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1328-34. PubMed ID: 16997505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surgical therapy of primary breast carcinoma--options and perspectives].
    Büchels HK
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1207-11. PubMed ID: 9574380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node staging surgery and breast cancer: potholes in the fast lane from more to less.
    Moffat FL
    J Surg Oncol; 2005 Feb; 89(2):53-60. PubMed ID: 15660377
    [No Abstract]   [Full Text] [Related]  

  • 12. The correlation of extranodal invasion with other prognostic parameters in lymph node positive breast cancer.
    Altinyollar H; Berberoğlu U; Gülben K; Irkin F
    J Surg Oncol; 2007 Jun; 95(7):567-71. PubMed ID: 17226805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpectoral approach to dissection of the axillary apex: an elegant and effective approach.
    Pai A; Gupta P; Raina S; Nadkarni MS; Parmar V; Badwe RA
    J Surg Oncol; 2006 Sep; 94(3):252-4. PubMed ID: 16900515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with breast cancer and positive sentinel nodes: axillary dissection or axillary radiotherapy?
    Zippel D; Papa M
    Arch Surg; 2003 Oct; 138(10):1159. PubMed ID: 14557139
    [No Abstract]   [Full Text] [Related]  

  • 15. Sentinel lymphadenectomy in primary breast carcinoma: an alternative to routine axillary dissection.
    Giuliano AE
    J Surg Oncol; 1996 Jun; 62(2):75-7. PubMed ID: 8649044
    [No Abstract]   [Full Text] [Related]  

  • 16. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is axillary dissection needed in node-positive breast cancer?
    Greenberg CC; Bafford AC; Golshan M
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):195-8. PubMed ID: 18279060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modified radical mastectomy in breast cancer].
    Kasumi F
    Gan No Rinsho; 1989 May; Spec No():227-35. PubMed ID: 2601013
    [No Abstract]   [Full Text] [Related]  

  • 19. Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer.
    Ahlgren J; Holmberg L; Bergh J; Liljegren G
    Eur J Surg Oncol; 2002 Mar; 28(2):97-102. PubMed ID: 11884042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields.
    Yu J; Li G; Li J; Wang Y
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):874-8. PubMed ID: 15708269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.